CIK: 1525354 - Address: 245 East 40Th Street, Apt. 18H, New York, NY 10016
36 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret113304417247421
P%wins55615248527657
S%ret113-41143712111848
S%wins676767033039

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/24/14 14:55
11/14/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYHFmr OffiS.dm-10,3578.844-1,172-401,765D31037-43-34-12-21-29-95225474265145
10/9/14 11:11
10/1/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP2038.1162512,995D62-49-4-22-117-4-5-5-43412183
10/9/14 11:11
10/1/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOS-30.01006-300-92,995D62-49-4-22-117-4-5-5-43412183
10/2/14 21:30
9/30/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP389.425402,937D33-63-31-29-33-19-15107-427162125
9/23/14 10:54
9/19/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP.m59111.1545322,933D47-44-8-15-26-18-72-8-1130116112
9/18/14 11:28
9/17/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP6911.463602,880D68-373-1-15-13-103-5-13-393156
9/16/14 19:51
9/16/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP8010.692802,874D68-31712-4-12-10-8-15-23-2019133
6/3/14 21:50
5/30/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOS-4,42715.146-292-92,867D113106-19418134-12-15-72-22127
4/7/14 10:16
4/4/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP15719.6415802,983D26219112709-7-11-5-19-33-38-4321
4/4/14 11:53
4/3/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP50822.60142312,975D31021316482230-10-14-35-39-5311
4/3/14 09:34
4/2/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP24122.28131102,952D35425923437322418-10-13-39-47-632
3/27/14 10:20
3/24/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP7017.618402,941D31124019493101812-514-36-43-478
3/21/14 13:36
3/20/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP9017.977502,937D244180175889110-41-28-43-3916
3/20/14 12:24
3/19/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP6518.447402,932D23116514281-6-94714-20-38-3723
3/17/14 16:15
3/14/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP6917.367402,929D26514312764-9-7-975-26-36-27-16
3/12/14 09:49
3/11/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP50419.4792612,925D323207119731981-1-27-40-33-20
3/11/14 10:45
3/10/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP20719.3291102,899D267230133832747-4-12-2-43-34-23
3/10/14 10:20
3/6/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP.m7518.529402,888D3402221448530153-10-7-46-31-22
3/6/14 09:32
3/5/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP7418.488402,884D3372091535074-251114-37-25-24
3/3/14 10:00
2/21/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP.m80418.6684322,880D302195152477010-71920-17-23-20
2/25/14 09:00
2/21/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP2817.567202,837D2921922171249378190-67-28-35-28
2/19/14 10:40
2/14/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP5114.606402,836D2701661608742524632216-16-23-6
2/7/14 12:52
2/6/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP209.922202,832D1851054738-14-741569371529
1/15/14 06:01
1/14/14
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP8710.842802,830D1991016951583230612445-228
1/14/14 19:04
9/12/13
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP.ad254.501602,669D1841027662724244613-417-319
1/2/14 06:41
12/31/13
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP.d1,0507.00115062,816D10943819-11401413512347875
12/10/13 14:33
12/6/13
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP.m28.210002,666D7225131637163-3-851324021
12/2/13 15:51
11/22/13
RTRXRetrophin, Inc.DEHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP.m36.310002,666D2480176-323752401629144
9/16/13 17:11
9/12/13
RTRXRetrophin, Inc.OKHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP.d504.5001102,671D5224211513106-3314873
8/23/13 14:15
8/21/13
RTRXRetrophin, Inc.OKHealthDrugPharmaceutical PreparationsShkreli MartinNYDOTCEOP.m246.060402,660D348793014-2-82-819289
3/12/13 13:31
3/6/13
RTRXRetrophin, Inc.OKFinancAcqCoBlank ChecksShkreli MartinNYDOTCEOP.m24.610102,656D-415223-318306238323
3/6/13 14:21
3/4/13
RTRXRetrophin, Inc.OKFinancAcqCoBlank ChecksShkreli MartinNYDOTCEOP44.430102,656D111621-12-332217541337
2/21/13 14:44
2/20/13
RTRXRetrophin, Inc.OKFinancAcqCoBlank ChecksShkreli MartinNYDOTCEOP54.160102,655D1096924122511355227305
2/19/13 16:14
2/14/13
RTRXDesert Gateway, Inc.OKFinancAcqCoBlank ChecksShkreli MartinNYDOTCEOP.d3603.00012052,654D1092581720-57256534265
2/13/13 18:41
2/12/13
RTRXDesert Gateway, Inc.OKFinancAcqCoBlank ChecksShkreli MartinNYDOTCEOP53.570102,534D1334-29-50-921811925187
12/28/12 12:30
12/17/12
RTRXDesert Gateway, Inc.OKFinancAcqCoBlank ChecksShkreli MartinNYDOTCEOP.m15.620002,532D54-34-60-25-78266979123

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact